Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.4950 (5.41%) ($7.4950 - $7.4950) on Mon. Aug. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.2% (three month average) | RSI | 59 | Latest Price | $7.4950(5.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.1% a day on average for past five trading days. | Weekly Trend | BCRX advances 0.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) SMH(65%) UNG(51%) XOP(33%) USO(30%) XLE(27%) | Factors Impacting BCRX price | BCRX will decline at least -1.6% in a week (0% probabilities). PCY(-32%) IGOV(-23%) SIL(-22%) SHY(-19%) VCSH(-18%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.6% (StdDev 3.2%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.1(5.56%) | 10 Day Moving Average | $7.07(6.01%) | 20 Day Moving Average | $7.21(3.95%) | To recent high | -15.4% | To recent low | 11.9% | Market Cap | $1.322b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |